Literature DB >> 33628146

Computer Simulation of Platelet Adhesion around Stent Struts in the Presence and Absence of Tissue Defects around Them.

Yota Kawamura1, Noriko Tamura2, Shinichi Goto3, Shinya Goto3.   

Abstract

AIM: To predict platelet accumulation around stent struts in the presence or absence of tissue defects around them.
METHODS: Computer simulations were performed using virtual platelets implementing the function of the three membrane proteins: glycoprotein (GP) Ibα, GPIIb/IIIa, and GPVI. These platelets were perfused around the stent struts implanted into the vessel wall in the presence or absence of tissue defects around them using within the simulation platform. The number of platelets that adhered around stent struts was calculated by solving the blood flow using Navier-Stokes equation along with the adhesion of membrane protein modeled within the platform.
RESULTS: Platelet accumulation around stent struts occurred mostly at the downstream region of the stent strut array. The majority of platelets adhered at the downstream of the first bend regardless of the tissue defect status. Platelet adhesion around stent struts occurred more rapidly in the presence of tissue defects.
CONCLUSION: Computer simulation using virtual platelets suggested a higher rate of platelet adhesion in the presence of tissue defects around stent struts.
Copyright © 2021 Yota Kawamura et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33628146      PMCID: PMC7895599          DOI: 10.1155/2021/8880988

Source DB:  PubMed          Journal:  J Interv Cardiol        ISSN: 0896-4327            Impact factor:   2.279


  48 in total

Review 1.  ST-segment elevation myocardial infarction.

Authors:  Birgit Vogel; Bimmer E Claessen; Suzanne V Arnold; Danny Chan; David J Cohen; Evangelos Giannitsis; C Michael Gibson; Shinya Goto; Hugo A Katus; Mathieu Kerneis; Takeshi Kimura; Vijay Kunadian; Duane S Pinto; Hiroki Shiomi; John A Spertus; P Gabriel Steg; Roxana Mehran
Journal:  Nat Rev Dis Primers       Date:  2019-06-06       Impact factor: 52.329

2.  The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study.

Authors:  Yukio Ozaki; Masanori Okumura; Tevfik F Ismail; Hiroyuki Naruse; Kousuke Hattori; Shino Kan; Makoto Ishikawa; Tomoko Kawai; Yasushi Takagi; Junichi Ishii; Francesco Prati; Patrick W Serruys
Journal:  Eur Heart J       Date:  2010-04-02       Impact factor: 29.983

3.  Functional significance of adenosine 5'-diphosphate receptor (P2Y(12)) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibalpha induced by conditions of high shear rate.

Authors:  Shinya Goto; Noriko Tamura; Koji Eto; Yasuo Ikeda; Shunnosuke Handa
Journal:  Circulation       Date:  2002-05-28       Impact factor: 29.690

4.  Co-localization of von Willebrand factor with platelet thrombi, tissue factor and platelets with fibrin, and consistent presence of inflammatory cells in coronary thrombi obtained by an aspiration device from patients with acute myocardial infarction.

Authors:  Y Hoshiba; K Hatakeyama; T Tanabe; Y Asada; S Goto
Journal:  J Thromb Haemost       Date:  2006-01       Impact factor: 5.824

5.  Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.

Authors:  Adnan Kastrati; Julinda Mehilli; Nicolas von Beckerath; Alban Dibra; Jörg Hausleiter; Jürgen Pache; Helmut Schühlen; Claus Schmitt; Josef Dirschinger; Albert Schömig
Journal:  JAMA       Date:  2005-01-12       Impact factor: 56.272

6.  Very late stent thrombosis in late stent malapposition after sirolimus-eluting stent implantation.

Authors:  Feng Zhang; Juying Qian; Junbo Ge
Journal:  Int Heart J       Date:  2007-09       Impact factor: 1.862

7.  Involvement of glycoprotein VI in platelet thrombus formation on both collagen and von Willebrand factor surfaces under flow conditions.

Authors:  Shinya Goto; Noriko Tamura; Shunnosuke Handa; Morio Arai; Kumi Kodama; Hiroshi Takayama
Journal:  Circulation       Date:  2002-07-09       Impact factor: 29.690

8.  A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

Authors:  M B Leon; D S Baim; J J Popma; P C Gordon; D E Cutlip; K K Ho; A Giambartolomei; D J Diver; D M Lasorda; D O Williams; S J Pocock; R E Kuntz
Journal:  N Engl J Med       Date:  1998-12-03       Impact factor: 91.245

Review 9.  The conundrum of late and very late stent thrombosis following drug-eluting stent implantation.

Authors:  Pallav Garg; Laura Mauri
Journal:  Curr Opin Cardiol       Date:  2007-11       Impact factor: 2.161

10.  Effectiveness and safety of drug-eluting stents in Ontario.

Authors:  Jack V Tu; James Bowen; Maria Chiu; Dennis T Ko; Peter C Austin; Yaohua He; Robert Hopkins; Jean-Eric Tarride; Gord Blackhouse; Charles Lazzam; Eric A Cohen; Ron Goeree
Journal:  N Engl J Med       Date:  2007-10-04       Impact factor: 91.245

View more
  1 in total

Review 1.  The Mechanisms of Restenosis and Relevance to Next Generation Stent Design.

Authors:  Jessie Clare; Justin Ganly; Christina A Bursill; Huseyin Sumer; Peter Kingshott; Judy B de Haan
Journal:  Biomolecules       Date:  2022-03-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.